St. Jude Develops More Affordable ALL Follow-up Test

Armen Hareyan's picture

Acute lymphoblastic leukemia treatment

Investigators at St. Jude Children's Research Hospital have developed a relatively simple and inexpensive test that identifies children with acute lymphoblastic leukemia (ALL) who have responded well enough to their first round of chemotherapy that they might be successfully treated with a much less aggressive follow-up treatment.
The new test could give hospitals with limited resources an affordable way to improve the outcome of